Immune Response BioPharma (United States)
- Research works
- 0 fractional, all time
- Citations
- 0 0.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Immune Response BioPharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Immune Response BioPharma (United States) publish most on?
By volume: Blood Coagulation and Thrombosis Mechanisms, Protease and Inhibitor Mechanisms and Rural and Ethnic Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
- 2 Protease and Inhibitor Mechanisms Cancer Research 0 works
- 3 Rural and Ethnic Education Education 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Atlantic City
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.